BioXcel Therapeutics
BTAI
#9966
Rank
A$49.72 M
Marketcap
A$2.27
Share price
-0.63%
Change (1 day)
-71.66%
Change (1 year)

Market capitalization of BioXcel Therapeutics (BTAI)

Market cap: A$49.72 Million

As of February 2026 BioXcel Therapeutics has a market cap of A$49.72 Million. This makes BioXcel Therapeutics the world's 9966th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioXcel Therapeutics from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026A$49.72 M-8.25%
2025A$54.2 M81.68%
2024A$29.83 M-76.46%
2023A$0.12 B-85.67%
2022A$0.88 B12.74%
2021A$0.78 B-46.52%
2020A$1.46 B288.69%
2019A$0.37 B339.78%
2018A$85.82 M

End of Day market cap according to different sources

On Feb 2nd, 2026 the market cap of BioXcel Therapeutics was reported to be:

A$49.72 Million
by Nasdaq info icon info icon
A$49.72 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
A$1.56 B 3,045.43%๐Ÿ‡บ๐Ÿ‡ธ USA